Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.
about
Mass spectrometry-based metabolite profiling in the mouse liver following exposure to ultraviolet B radiationTranslational approaches: from fatty liver to non-alcoholic steatohepatitis.Reduced oxidative stress contributes to the lipid lowering effects of isoquercitrin in free fatty acids induced hepatocytes.Specific inhibition of the redox activity of ape1/ref-1 by e3330 blocks tnf-α-induced activation of IL-8 production in liver cancer cell linesWhat does irritable bowel syndrome share with non-alcoholic fatty liver disease?Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.H-rev107 Regulates Cytochrome P450 Reductase Activity and Increases Lipid Accumulation.Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in PodocytesGlial cell line-derived neurotrophic factor-induced mice liver defatting: A novel strategy to enable transplantation of steatotic livers.Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic DeviceFree Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchmiR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.Hepatitis C Virus Increases Free Fatty Acids Absorption and Promotes its Replication Via Down-Regulating GADD45α Expression.Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1.SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver disease.Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis.The role of gastrointestinal hormones in hepatic lipid metabolism.Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study.Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro.Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients.Role of thrombospondin 1 in liver diseases.Elevated cholesterol levels have a poor prognosis in a cholestasis scenario.Cirsium brevicaule A. GRAY leaf inhibits adipogenesis in 3T3-L1 cells and C57BL/6 mice.Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease.Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease.Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis.A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.Hepatosteatosis and hepatic insulin resistance are blunted by argirein, an anti-inflammatory agent, through normalizing endoplasmic reticulum stress and apoptosis in diabetic liver.Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.Insulin-Like Growth Factor (IGF) System in Liver Diseases.Improvement of non-alcoholic steatohepatitis by hepatocyte-like cells generated from iPSCs with Oct4/Sox2/Klf4/Parp1.Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells.
P2860
Q28543503-E1A68548-4E64-43C3-AE21-FEE3691AA80AQ33958697-D0E42CC1-411A-4979-86AA-36224C86251EQ34488103-5384CAAC-EAE0-49ED-82B4-B9C389906834Q34963206-187A3FE0-8D70-47E4-A90D-F17189193521Q34983471-94031F34-8A69-4A2B-8CCB-9EB9E7330B83Q35107757-72D840B4-16C0-40A5-98AB-3E673413031EQ35779396-48690135-5414-46D5-B7DD-4413BD76F862Q35834459-0EBAF462-6293-4FB5-A76D-3D6B32D68DE7Q35880917-29613523-0510-49A1-8279-39B2AA34C234Q36082853-3B415737-CB97-4E2D-BB7E-0FC282F11EA4Q36084783-DA36BBC6-E1E9-405D-8287-8423D0A7F7DDQ36129673-97D3762B-C03E-437A-89FA-389BF5878020Q36504308-E1D429B6-E3CB-4B3B-8334-B431D302135FQ37097593-E4D4F972-DA04-4CA4-8774-03672ACD4347Q37358301-B8868DB5-900F-45C9-8D10-72B305E9C573Q37419220-BE729E7F-4E3C-4668-A79D-33F2380E433BQ37575764-E7C4912C-198D-44D4-A564-506DBB50F4CCQ37640700-A8D2BF76-20BA-4BA8-966E-8CF8E6666637Q37733119-8BF0BAD2-90CC-4224-8F87-FC749AC7D971Q38310825-C191834C-2D56-4E85-BB06-B873F4080D64Q38710403-B3783362-CA62-4852-BA8F-008EBE0BE268Q38918913-9706AAAA-B1A6-47D9-85F5-E49C18A6D579Q38925850-B65D94F8-4EAB-45C9-9152-F0A97098E49CQ39094141-28CA056B-1D61-4E38-B9B3-8494E3118EE8Q39140524-012C5D81-AB52-4D5F-800A-F72C16DDD063Q40683672-8DA717CF-99B3-4501-BA00-1D0511574F79Q41817046-6931D4B9-D3FC-4DE7-8768-8C34047A4807Q46413321-17E383D9-3EFB-4044-98AE-AC56F736DE99Q51016955-D91C68C4-20DA-476B-8EE3-65BA8B052FBBQ51785654-4240AAD1-74B5-4216-A227-BC37CE0A6785Q52558393-4715030F-4BEE-4D85-B9C5-DA2AF293FB5FQ52714594-0E18A010-3F60-4FBD-85A4-0EAAD3EC89BDQ55088579-AFD4066A-86FE-4F39-AFF6-5CC2E205E553
P2860
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Effect of intracellular lipid ...... alcoholic fatty liver disease.
@ast
Effect of intracellular lipid ...... alcoholic fatty liver disease.
@en
Effect of intracellular lipid ...... alcoholic fatty liver disease.
@nl
type
label
Effect of intracellular lipid ...... alcoholic fatty liver disease.
@ast
Effect of intracellular lipid ...... alcoholic fatty liver disease.
@en
Effect of intracellular lipid ...... alcoholic fatty liver disease.
@nl
prefLabel
Effect of intracellular lipid ...... alcoholic fatty liver disease.
@ast
Effect of intracellular lipid ...... alcoholic fatty liver disease.
@en
Effect of intracellular lipid ...... alcoholic fatty liver disease.
@nl
P2860
P356
P1433
P1476
Effect of intracellular lipid ...... alcoholic fatty liver disease.
@en
P2093
Claudio Tiribelli
Natalia Rosso
P2860
P2888
P356
10.1186/1471-230X-12-20
P577
2012-03-01T00:00:00Z
P6179
1025381096